ALS News Today4h
Biopharmaceutical launches with goal to develop treatment for ALS
Trace Neuroscience has launched in the U.S. with over $100 million in financing and a goal to develop its UNC13A-targeted treatment for ALS.
ALS News Today1d
Reading others’ stories reminds me that I’m not alone
Columnist Kristin Neva sometimes get overwhelmed by her increasing caregiver responsibilities, but it helps her to know she's not alone.
ALS News Today1d
Research grant provides $7.3M for NU-9 development
The National Institute of Aging awarded a $7.3 million research grant for the study of NU-9 as a treatment for ...
ALS News Today2d
Kadimastem, NLS merge to advance ALS therapy AstroRx, other drugs
Kadimastem, the developer of the experimental amyotrophic lateral sclerosis (ALS) therapy AstroRx, is merging with NLS ...
ALS News Today3d
Mitochondrial genome mutations linked to ALS in genetic study
Mitochondrial genome mutations may be linked to ALS, per a study, opening the door for new ways to diagnosing and treating ...